Pharma Journalist - Page 96 of 957 -

Cognizant Extends Gilead Partnership to Expand AI-Enabled DevOps

CSL, Alentis Partner on $1.55B Kidney and Liver Drug

Alector Licenses Parkinson’s Drug Program to Genentech for $1.27B

FDA Expands GE HealthCare’s Vizamyl Indications for Enhanced Alzheimer’s Beta Amyloid Detection

FDA Approves Benlysta Autoinjector for Pediatric Lupus Nephritis

Gilead and Kymera Partner on Novel Oral CDK2 Degraders in Exclusive License Deal

FDA Approves Updated Label for Lilly’s Amyvid to Aid Alzheimer’s Diagnosis

Vor Bio, RemeGen Sign Exclusive Global License Deal for Late-Stage Autoimmune Therapy

Medera’s Novoheart Teams Up to Develop Mini-Heart Models for Hypoplastic Left Heart Syndrome Treatment

Novo Nordisk’s Ozempic Recommended by EU for Peripheral Arterial Disease in Type 2 Diabetes

Datroway Approved in U.S. for Advanced EGFR-Mutated Lung Cancer

argenx Wins EU Approval for VYVGART SC to Treat CIDP

Harbour BioMed and Otsuka Partner Globally to Develop BCMAxCD3 Bispecific T-Cell Engagers